The Role of the Wearable Cardioverter Defibrillator in Clinical Practice

Zipes, 2006, J Am Coll Cardiol, 48, e247, 10.1016/j.jacc.2006.07.010

Gronda, 2006, Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates–2006, J Heart Lung Transplant, 25, 1043, 10.1016/j.healun.2006.06.005

Wilkoff, 2009, Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA), Heart Rhythm, 6, 1085, 10.1016/j.hrthm.2009.05.020

O'Gara, 2013, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 61, e78, 10.1016/j.jacc.2012.11.019

Chung, 2010, Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival, J Am Coll Cardiol, 56, 194, 10.1016/j.jacc.2010.04.016

Moss, 1996, Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators, N Engl J Med, 335, 1933, 10.1056/NEJM199612263352601

Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474

Bardy, 2005, Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 352, 225, 10.1056/NEJMoa043399

Buxton, 1999, A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators, N Engl J Med, 341, 1882, 10.1056/NEJM199912163412503

Bigger, 1997, Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators, N Engl J Med, 337, 1569, 10.1056/NEJM199711273372201

Kadish, 2004, Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy, N Engl J Med, 350, 2151, 10.1056/NEJMoa033088

Epstein, 2008, Circulation, 117, e350, 10.1161/CIRCUALTIONAHA.108.189742

Solomon, 2001, Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study, Ann Intern Med, 134, 451, 10.7326/0003-4819-134-6-200103200-00009

Solomon, 2005, Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both, N Engl J Med, 352, 2581, 10.1056/NEJMoa043938

Klein, 2010, Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD), Pacing Clin Electrophysiol, 33, 353, 10.1111/j.1540-8159.2009.02590.x

Bunch, 2011, Trends in early and late mortality in patients undergoing coronary catheterization for myocardial infarction: implications on observation periods and risk factors to determine ICD candidacy, Heart Rhythm, 8, 1460, 10.1016/j.hrthm.2011.03.052

Adabag, 2008, Sudden death after myocardial infarction, JAMA, 300, 2022, 10.1001/jama.2008.553

Goldberger, 2009, Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking, J Am Coll Cardiol, 54, 2001, 10.1016/j.jacc.2009.08.018

Pouleur, 2010, Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both, Circulation, 122, 597, 10.1161/CIRCULATIONAHA.110.940619

Piccini, 2011, Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), Heart Rhythm, 8, 393, 10.1016/j.hrthm.2010.11.033

Hohnloser, 2004, Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction, N Engl J Med, 351, 2481, 10.1056/NEJMoa041489

Steinbeck, 2009, Defibrillator implantation early after myocardial infarction, N Engl J Med, 361, 1427, 10.1056/NEJMoa0901889

Feldman, 2004, Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD, Pacing Clin Electrophysiol, 27, 4, 10.1111/j.1540-8159.2004.00378.x

Epstein, 2013, Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post myocardial infarction, J Am Coll Cardiol, 62, 2000, 10.1016/j.jacc.2013.05.086

Nageh, 2011, The role of implantable cardioverter defibrillators in high-risk CABG patients identified early post-cardiac surgery, Europace, 13, 70, 10.1093/europace/euq351

John, 2010, Underutilization of implantable cardioverter defibrillators post coronary artery bypass grafting in patients with systolic dysfunction, Pacing Clin Electrophysiol, 33, 727, 10.1111/j.1540-8159.2010.02700.x

Bonow, 2011, Myocardial viability and survival in ischemic left ventricular dysfunction, N Engl J Med, 364, 1617, 10.1056/NEJMoa1100358

Shahian, 2012, Predictors of long-term survival after coronary artery bypass grafting surgery: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (the ASCERT study), Circulation, 125, 1491, 10.1161/CIRCULATIONAHA.111.066902

Halkin, 2005, Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score, J Am Coll Cardiol, 45, 1397, 10.1016/j.jacc.2005.01.041

Weintraub, 2012, Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry, Circulation, 125, 1501, 10.1161/CIRCULATIONAHA.111.066969

Zishiri, 2013, Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator, Circ Arrhythm Electrophysiol, 6, 117, 10.1161/CIRCEP.112.973552

Verdino, 2010, The wearable cardioverter-defibrillator: lifesaving attire or “fashion faux pas?”, J Am Coll Cardiol, 56, 204, 10.1016/j.jacc.2010.04.015

Schliamser, 2013, Significance of follow-up left ventricular ejection fraction measurements in the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE), Heart Rhythm, 10, 838, 10.1016/j.hrthm.2013.02.017

Bardy, 2000, The sudden cardiac death-heart failure trial (SCD-HeFT), 323

Kadish, 2006, Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators, J Am Coll Cardiol, 47, 2477, 10.1016/j.jacc.2005.11.090

Makati, 2006, Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more, Heart Rhythm, 3, 397, 10.1016/j.hrthm.2006.01.012

Lang, 2003, Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home, J Heart Lung Transplant, 22, 419, 10.1016/S1053-2498(02)00570-3

Cantillon, 2010, Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator, Heart Rhythm, 7, 466, 10.1016/j.hrthm.2009.12.022

Auricchio, 1998, Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation, Am J Cardiol, 81, 1253, 10.1016/S0002-9149(98)00120-9

Sweeney, 2005, Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT Reduces Shock Therapies (PainFREE Rx II) trial, Circulation, 111, 2898, 10.1161/CIRCULATIONAHA.104.526673

Poole, 2008, Prognostic importance of defibrillator shocks in patients with heart failure, N Engl J Med, 359, 1009, 10.1056/NEJMoa071098

Daubert, 2008, Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact, J Am Coll Cardiol, 51, 1357, 10.1016/j.jacc.2007.09.073

Klein, 2003, Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial, J Cardiovasc Electrophysiol, 14, 940, 10.1046/j.1540-8167.2003.01554.x

Wilkoff, 2006, A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial, J Am Coll Cardiol, 48, 330, 10.1016/j.jacc.2006.03.037

Wilkoff, 2008, Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study, J Am Coll Cardiol, 52, 541, 10.1016/j.jacc.2008.05.011

Wilkoff, 2004, Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients, J Cardiovasc Electrophysiol, 15, 1002, 10.1046/j.1540-8167.2004.03625.x

Everitt, 2010, Use of the wearable external cardiac defibrillator in children, Pacing Clin Electrophysiol, 33, 742, 10.1111/j.1540-8159.2010.02702.x

Reek, 2003, Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks, Pacing Clin Electrophysiol, 26, 2016, 10.1046/j.1460-9592.2003.00311.x

Dillon, 2010, Evaluation of the effectiveness of a wearable cardioverter defibrillator detection algorithm, J Electrocardiol, 43, 63, 10.1016/j.jelectrocard.2009.05.010

Rao, 2011, Wearable defibrillator in congenital structural heart disease and inherited arrhythmias, Am J Cardiol, 108, 1632, 10.1016/j.amjcard.2011.07.021

Saltzberg, 2012, Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator, J Card Fail, 18, 21, 10.1016/j.cardfail.2011.09.004